The goal of this observational study is to determine the urinary proteomic characteristics in women with and without ovarian cancer. The main questions it aims to answer are:
1. What is the difference in urinary protein composition between patients with ovarian cancer and those without it? 2. Can these differences in urinary protein composition aid in the diagnosis of ovarian cancer? 3. Are urinary protein markers associated with tumor burden in urine samples from patients with ovarian cancer? 4. Can urinary protein markers be used for disease surveillance in ovarian cancer patients?
Female patients in the gynecological ward for surgical treatment.
Initial diagnosis of "pelvic mass" or "malignant ascites" may be considered as ovarian cancer; Or the initial diagnosis of "ovarian cyst", "hydrosalpinx", "uterine fibroids" or "uterine adenomyosis" are considered as gynecological non-malignant diseases.
Over 18 years of age.
Voluntary participation and signing of informed consent.
Study participants with a prior history of malignant tumors.
Study participants with prior chronic kidney disease or renal insufficiency.
Study participants who have received or are receiving treatment for primary disease.
Study participants whose pathological diagnosis was not clear.
primary care clinic
Cohort
Prospective
Not listed
Pathological diagnosis
The histological type of the disease is confirmed by surgery or biopsy
Progression
Patients with ovarian cancer who have recurrent disease after initial treatment with serological or imaging evidence
Click on the lead sponsor to view all of their trials.
